Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Leuk Res. 2021 Oct 21;111:106733. doi: 10.1016/j.leukres.2021.106733

Table 2.

Prognostic impact of MYC expression on MDS-to-AML PFS in the univariate and multivariate (cox-regression) analyses.

MDS-to-AML progression free survival
Univariate Multivariate
Variables HR 95% CI P value HR 95% CI P value
High MYC 2.328 1.194-4.535 0.013 2.275 1.016-5.096 0.046
IPSS 1.617 1.061-2.464 0.025 1.632 1.042-2.557 0.032
Age 1.018 0.992-1.045 0.167 1.019 0.989-1.049 0.213
Allo-SCT 0.704 0.215-2.303 0.562 0.462 0.128-1.663 0.237

Abbreviation: HR (hazard ratio), CI (confidence interval), IPSS (international prognostic scoring system), Allo-SCT (allogeneic stem cell transplant).